<DOC>
	<DOCNO>NCT00003067</DOCNO>
	<brief_summary>RATIONALE : Biological therapy use different way stimulate immune system stop cancer cell grow . Interleukin-2 may stimulate person 's white blood cell kill cancer cell patient primary advanced glioma . PURPOSE : Clinical trial study effectiveness biological therapy interleukin-2 lymphokine-activated killer cell treat patient primary , recurrent , refractory malignant glioma .</brief_summary>
	<brief_title>Biological Therapy Treating Patients With Primary Advanced Glioma</brief_title>
	<detailed_description>OBJECTIVES : - Confirm antitumor efficacy intracavitary interleukin-2 plus autologous lymphokine-activated killer cell patient primary , recurrent refractory malignant glioma . - Determine whether induction regional , intracavitary , eosinophilia prognosticator response immunotherapy long term survival patient . OUTLINE : Patients receive cytoreductive tumor surgery and/or biopsy implantation intracavitary Ommaya reservoir prior therapy induction . Patients undergo outpatient leukapheresis day -4 -5 , cell incubate ex vivo interleukin-2 ( IL-2 ) . Lymphokine-activated killer ( LAK ) cell IL-2 infused day 1 . Bolus infusion low-dose IL-2 administer day 3 , 5 , 8 , 10 , 12 , follow rest period day 13-24 . The course repeat day 25 start leukapheresis . Therapy course repeat 1 year stable disease response therapy . Maintenance dose repeat every 4-6 month thereafter . Disease restaging do every 8-12 week . PROJECTED ACCRUAL : A total 30 patient per year enrol .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Aldesleukin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically radiographically proven primary , recurrent , refractory malignant glioma ( glioblastoma , anaplastic astrocytoma , mixed anaplastic glioma ) Must candidate neurosurgical biopsy tumor debulking PATIENT CHARACTERISTICS : Age : 18 Performance Status : Karnofsky 60100 % Life Expectancy : Greater 4 month Hematopoietic : Granulocytes great 1,500/mm^3 Platelet count great 50,000/mm^3 PT PTT within normal limit Hepatic : Bilirubin great 1.5 time upper limit normal Renal : Creatinine le 1.5 mg/dL Creatinine clearance great 60 mL/min Cardiovascular : No congestive heart failure No coronary artery disease No serious cardiac arrhythmias No prior myocardial infarction Pulmonary : No major pulmonary problem Other : No history neurologic disease ( except relate brain tumor ) No psychosis No impaired cognitive function No significant concurrent medical illness No active infection require antibiotic therapy Not pregnant Negative pregnancy test Fertile patient must use effective contraception Adequate peripheral vein permit leukapheresis , placement indwell central vascular access device No hepatitis B C HIV negative No prior autoimmune disease Allergy gentamicin allow PRIOR CONCURRENT THERAPY : Biologic therapy : At least 6 week since prior immunotherapy recover No concurrent immunotherapy Chemotherapy : At least 4 week since prior chemotherapy ( 6 week carmustine ) recover No concurrent chemotherapy Endocrine therapy : Reduction elimination corticosteroid Not great 0.15 mg/kg/day dexamethasone equivalent Radiotherapy : At least 6 week since prior radiotherapy recover No concurrent radiotherapy Surgery : Prior surgery allow Other : Concurrent therapy acetaminophen , anticonvulsant agent , headache pain medication allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>